PUBLISHER: Grand View Research | PRODUCT CODE: 1609957
PUBLISHER: Grand View Research | PRODUCT CODE: 1609957
The global veterinary chemistry analyzer market size is estimated to reach USD 5.63 billion by 2030, registering to grow at a CAGR of 13.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. Increasing pet ownership, rising animal healthcare expenditure, growing pet insurance industry, and increasing zoonotic diseases are some of the major factors contributing to the growth of the market.
The increasing incidence of zoonotic diseases is one of the key trends escalating market growth. According to the WHO, zoonoses are estimated to cause about a billion cases of disease and millions of fatalities each year globally. Zoonoses account for over 60% of new infectious illnesses that are reported globally. The global outbreak of COVID-19 has impacted all industries. Vet clinics and hospitals across various key geographies registered low patient volume while some directed resources to focus only on emergency cases. The stay-at-home policies resulted in decreased companion animal clinical visits, including delay of wellness visits and elective procedures, thus lowering the demand for chemistry testing services.
The demand gradually recovered during the second and third quarters of 2020. Presently, continuous innovation and strategies adopted by market players in the animal diagnostics sector support market growth. For instance, according to a July 2022 KED Global News Network story, Precision, a Korean in vitro diagnostics company, will introduce veterinary clinical chemistry analyzers to the U.S. market. Antech Diagnostics Inc. and Precision have a contract for the provision of Exdia PT10V, a vet clinical chemistry analyzer, valued USD 90.3 million. With the signing of this agreement, Antech is prepared to use Precision's products to enter the veterinary clinical chemistry industry.